Neurological Symptoms in occult Brain Metastases of the Melanoma after first Application of an Anti-PD1 Antibody

被引：0
|
作者：
Graetz, V [1 ]
Luettmann, V [1 ]
Haase, O. [1 ]
Neumann, A. [1 ]
Zillikens, D. [1 ]
Terheyden, P. [1 ]
机构：
[1] UKSH Lubeck, Dermatol, Lubeck, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2016年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
FV2
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [1] The Effects of Brain Metastases in Melanoma Patients on anti-PD1 Antibody Therapy with Pembrolizumab
    Weichenthal, M.
    Mohr, P.
    Leiter-Stoeppke, U.
    Ugurel, S.
    Kaehler, K.
    Gutzmer, R.
    Pfoehler, C.
    Hassel, J. C.
    Nashan, D.
    Terheyden, P.
    Schell, B.
    Utikal, J. S.
    Kreuter, A.
    Haferkamp, S.
    Kaune, K.
    Berking, C.
    Debus, D.
    Ulrich, J.
    Dabrowski, E.
    Eigentler, T.
    Welzel, J.
    Herbst, R.
    Loquai, C.
    Meier, F.
    Schadendorf, D.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 5 - 6
  • [2] Tolerance and outcomes of stereotactic radiosurgery combined with anti-PD1 (pembrolizumab) for melanoma brain metastases
    Nardin, C.
    Mateus, C.
    Texier, M.
    Lanoy, E.
    Hibat-Allah, S.
    Ammari, S.
    Robert, C.
    Dhermain, F.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [3] TOLERANCE AND OUTCOMES OF STEREOTACTIC RADIOSURGERY COMBINED WITH ANTI-PD1 (PEMBROLIZUMAB) FOR MELANOMA BRAIN METASTASES
    Nardin, Charlee
    Mateus, Christine
    Texier, Matthieu
    Lanoy, Emilie
    Hibat-Allah, Salima
    Ammari, Sami
    Robert, Caroline
    Dhermain, Frederic
    [J]. NEURO-ONCOLOGY, 2017, 19 : 43 - 43
  • [4] Safety and results of anti-PD1 combined with radiosurgery for the treatment of melanoma brain metastases.
    Marqueste, Caroline Gaudy
    Carron, Romain
    Amatore, Florent
    Malissen, Nausicaa
    Muracciole, Xavier
    Loundou, Anderson
    Troin, Laura
    Monestier, Sandrine
    Mallet, Stephanie
    Richard, Marie-Aleth
    Regis, Jean
    Grob, Jean Jacques
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Metastatic site and response to pembrolizumab (anti-PD1 antibody) in melanoma
    Tumeh, Paul Camille
    Rosenblum, Michael
    Handley, Nathan
    Tsai, Katy
    Rodriguez, Robert S. Rodriguez
    Khurana, Niharika
    Harview, Christina
    Spasic, Marko
    Sanchez, Phillip J.
    Chang, Jeremy
    Shintaku, I. Peter
    Taylor, Emma
    Chmielowski, Bartosz
    Grogan, Tristan
    Elashoff, David A.
    Pierce, Robert H.
    Daud, Adil
    [J]. CANCER RESEARCH, 2015, 75
  • [6] Stereotactic radiosurgery combined with anti-PD1 for the management of melanoma brain metastases: A retrospective study of safety and efficacy
    Carron, Romain
    Gaudy-Marqueste, Caroline
    Amatore, Florent
    Padovani, Laetitia
    Malissen, Nausicaa
    Balossier, Anne
    Loundou, Anderson
    Bonnet, Nathalie
    Muracciole, Xavier
    Regis, Jean-Marie
    Grob, Jean-Jacques
    [J]. EUROPEAN JOURNAL OF CANCER, 2020, 135 : 52 - 61
  • [7] Arthritis and Tenosynovitis Associated With the Anti-PD1 Antibody Pembrolizumab in Metastatic Melanoma
    Chan, Matthew M. K.
    Kefford, Richard F.
    Carlino, Matteo
    Clements, Arthur
    Manoliosz, Nicholas
    [J]. JOURNAL OF IMMUNOTHERAPY, 2015, 38 (01) : 37 - 39
  • [8] VEDOLIZUMAB PLUS ANTI-PD1 ANTIBODY IN ADVANCED MELANOMA PATIENTS WITH INFLAMMATORY ENTEROCOLITIS
    Javed, Asad
    Freesmeier, Michele
    Zakharia, Yousef
    Milhem, Mohammed
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1313 - A1313
  • [9] Anti-PD1 and anti-PD-L1 in the treatment of metastatic melanoma
    Simeone, Ester
    Grimaldi, Antonio M.
    Ascierto, Paolo A.
    [J]. MELANOMA MANAGEMENT, 2015, 2 (01) : 41 - 50
  • [10] Anti-PD1 role in treatment of cutaneous melanoma
    Mateus, Christine
    Libenciuc, Cristina
    Robert, Caroline
    [J]. BULLETIN DU CANCER, 2016, 103 (06) : S4 - S11
12345